Multiple studies have demonstrated dihydropyridine calcium‐channel blocker (CCB) therapy
to be appropriate for the treatment of hypertension, as is reflected in treatment guidelines …

Background Lacidipine is a widely used calcium-channel blocker, which has both long-
lasting antihypertensive activity and also antioxidant properties. Previous studies have …

Calcium antagonists are effective in hypertensive patients of all ethnic groups, irrespective of
age, dietary salt intake, salt-sensitivity status or plasma renin activity profile. Some …

Calcium channel blockers (CCBs), particularly dihydropyridine-CCBs,(DHP-CCBs), have an
established role in antihypertensive therapy, either as monotherapy or in combination with …

Several types of calcium antagonists (CA)(verapamil, diltiazem, nifedipine and related
drugs) may be used as antihypertensives. In practice, the dihydropyridines (nifedipine and …

Synopsis Since the earlier review in Drugs substantial additional data have accumulated
regarding the antihypertensive efficacy of isradipine in various clinical situations, as well as …

The newer dihydropyridine calcium antagonists are structurally related to nifedipine, but may
provide greater vascular selectivity and wider clinical utility. Five new dihydropyridines …

Calcium channel blockers (CCBs), which include both dihydropyridines such as nifedipine
and amlodipine and non‐dihydropyridines (verapamil and diltiazem), are among the most …

Hypertension is one of the most common conditions seen in primary care and a major public
health problem in India. It can lead to various complications if not detected early and treated …

To investigate the efficacy and tolerability of lercanidipine, used as monotherapy once a day,
in elderly patients with isolated systolic hypertension (ISH), 83 patients were enrolled in this …